Among the mechanisms that have been suggested are gene-environment interactions affecting ε4 allele of the apolipoprotein E (APOE) [78], triggering inflammation in the brain [79] resulting in accumulation of amyloid-beta peptide (Aβx-42 peptide, an important early biomarker of AD) [80]. Here, APOE is linked to Alzheimer disease.